上海
分享至
财联社8月7日电，再鼎医药(09688.HK)在港交所发布中期业绩报告，期内总收入约2.16亿美元，同比增长15.35%；净亏损8916.5万美元，同比收窄33.33%。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
